Mesenchymal stem cells (MSCs) have the ability to migrate to the site of injury or inflammation, and to contribute to the healing process. Since patients treated with MSCs are often users of analgesic drugs, to relieve their uncomfortable pain associated with the tissue disorder, there is a possibility of negative effects of these drugs on the migration of endogenous and exogenous MSCs. Therefore, we tested the impact of acute and chronic treatment with morphine on the migration and organ distribution of exogenous adipose tissue-derived MSCs in mouse models. Firstly, we showed that the incubation of MSCs with morphine significantly reduced the expression of adhesive molecules CD44 (HCAM), CD54 (ICAM-1) and CD106 (VCAM-1) on MSCs. Using a model of systemic administration of MSCs labeled with vital dye PKH26 and by the application of flow cytometry to detect living CD45−PKH26+ cells, we found a decreased number of labeled MSCs in the lung, spleen and bone marrow, and a significantly increased number of MSCs in the liver of morphine-treated recipients. A skin allograft model was used to study the effects of morphine on the migration of exogenous MSCs to the superficial wound. Intraperitoneally administered MSCs migrated preferentially to the wound site, and this migration was significantly decreased in the morphine-treated recipients. The present results showed that morphine significantly influences the distribution of exogenous MSCs in the body, and decreases their migration to the site of injury.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
The authors comfirm that all data and materials support the published claims and comply with field standards.
Sasaki, M., Abe, R., Fujita, Y., Ando, S., Inokuma, D., & Shimizu, H. (2008). Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. Journal of Immunology, 180, 2581–2587.
Lan, Y., Kodati, S., Lee, H. S., Omoto, M., Jin, Y., & Chauhan, S. K. (2012). Kinetics and function of mesenchymal stem cells in corneal injury. Investigative Ophthalmology and Visual Sciences, 53, 3638–3644.
Javorkova, E., Trosan, P., Zajicova, A., Krulova, M., Hajkova, M., & Holan, V. (2014). Modulation of the early inflammatory microenvironment in the alkali-burned eye by systemically administered interferon-γ-treated mesenchymal stromal cells. Stem Cells and Development, 23, 2490–2500.
Assis, A. C., Carvalho, J. L., Jacoby, B. A., Ferreira, R. L., Castanheira, P., Diniz, S. O., Cardoso, V. N., Goes, A. M., & Ferreira, A. J. (2010). Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart. Cell Transplantation, 19, 219–230.
Wu, Y., & Zhao, R. C. (2012). The role of chemokines in mesenchymal stem cell homing to myocardium. Stem Cell Reviews and Reports, 8, 243–250.
Singh, A., Singh, A., & Sen, D. (2016). Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015). Stem Cell Research and Therapy, 7(1), 82. https://doi.org/10.1186/s13287-016-0341-0.
Cardenes, N., Aranda-Valderrama, P., Carney, J. P., Sellares Torres, J., Alvarez, D., Kocydirim, E., Wolfram Smith, J. A., Ting, A. E., Lagazzi, L., Yu, Z., Mason, S., Santos, E., Lopresti, B. J., & Rojas, M. (2019). Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model. BMJ Open Respiratory Research. https://doi.org/10.1136/bmjresp-2018-000308.
Hajkova, M., Jaburek, F., Porubska, B., Bohacova, P., Holan, V., & Krulova, M. (2019). Cyclosporine A promotes the therapeutic effect of mesenchymal stem cells on transplantation reaction. Clinical Science (London), 133, 2143–2157.
Eggenhofer, E., Benseler, V., Kroemer, A., Popp, F. C., Geissler, E. K., Schlitt, H. J., Baan, C. C., Dahlke, M. H., & Hoogduijn, M. J. (2012). Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Frontiers in Immunology, 3, 297.
Leibacher, J., & Henschler, R. (2016). Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells. Stem Cell Research and Therapy, 7, 7. https://doi.org/10.1186/s13287-015-0271-2.
Ji, J. F., He, B. P., Dheen, S. T., & Tay, S. S. (2004). Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells, 22, 415–427.
Chamberlain, G., Wright, K., Rot, A., Ashton, B., & Middleton, J. (2008). Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS One, 3(8), e2934. https://doi.org/10.1371/journal.pone.0002934.
Rankin, S. M. (2012). Chemokines and adult bone marrow stem cells. Immunology Letters, 145, 47–54.
Nitzsche, F., Müller, C., Lukomska, B., Jolkkonen, J., Deten, A., & Boltze, J. (2017). Concise Review: MSC adhesion cascade-insights into homing and transendothelial migration. Stem Cells, 35, 1446–1460.
Abumaree, M., Al Jumah, M., Pace, R. A., & Kalionis, B. (2012). Immunosuppressive properties of mesenchymal stem cells. Stem Cell Reviews, 8, 375–392.
English, K. (2013). Mechanisms of mesenchymal stromal cell immunomodulation. Immunology and Cell Biology, 91, 19–26.
Holan, V., Hermankova, B., Bohacova, P., Kossl, J., Chudickova, M., Hajkova, M., Krulova, M., Zajicova, A., & Javorkova, E. (2016). Distinct immunoregulatory mechanisms in mesenchymal stem cells: Role of the cytokine environment. Stem Cell Reviews, 12, 654–663.
Bayer, R., Franke., H., Ficker, C., Richter, M., Lessig, R., Büttner, A., & Weber, M. (2015). Alterations of neuronal precursor cells in stages of human adult neurogenesis in heroin addicts. Drug and Alcohol Dependence, 156, 139–149.
Barlass, U., Dutta, R., Cheema, H., George, J., Sareen, A., Dixit, A., Yuan, Z., Giri, B., Meng, J., Banerjee, S., Banerjee, S., Dudeja, V., Dawra, R. K., Roy, S., & Saluja, A. K. (2017). Morphine worsens the severity and prevents pancreatic regeneration in mouse models of acute pancreatitis. Gut. https://doi.org/10.1136/gutjnl-2017-313717.
Wang, Y., Gupta, M., Farooqui, M., Li, Y., Peng, F., Rao, S., Ansonoff, M., Pintar, J. E., & Gupta, K. (2017). Opioids and opioid receptors orchestrate wound repair. Translational Research, 185, 13–23.
Holan, V., Cechova, K., Zajicova, A., Kossl, J., Hermankova, B., Bohacova, P., Hajkova, M., Krulova, M., Svoboda, P., & Javorkova, E. (2018). The impact of morphine on the characteristics and function properties of human mesenchymal stem cells. Stem Cell Reviews and Reports, 14, 801–811.
Hajkova, M., Javorkova, E., Zajicova, A., Trosan, P., Holan, V., & Krulova, M. (2017). A local application of mesenchymal stem cells and cyclosporine A attenuates immune response by a switch in macrophage phenotype. Journal of Tissue Engineering and Regenerative. Medicine, 11, 1456–1465.
Billingham, R. E., Brent, L., Medawar, P. B., & Sparrow, E. M. (1954). Quantitative studies on tissue transplantation immunity. I. The survival times of skin homografts exchanged between members of different inbred strains of mice. Proceedings of the Royal Society of London B: Biological Sciences, 143, 43–58.
Rook, J. M., & McCarson, K. E. (2007). Delay of cutaneous wound closure by morphine via local blockade of peripheral tachykinin release. Biochemical Pharmacology, 74, 752–757.
Bortolotto, V., & Grilli, M. (2017). Opiate analgesics as negative modulators of adult hippocampal neurogenesis: Potential implications in clinical practice. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2017.00254.
Lam, C. F., Chang, P. J., Huang, Y. S., et al. (2008). Prolonged use of high-dose morphine impairs angiogenesis and mobilization of endothelial progenitor cells in mice. Anesthesia and Analgesia, 107, 686–692.
Zhang, J., Huang, X., Wang, H., Liu, X., Zhang, T., Wang, Y., & Hu, D. (2015). The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy. Stem Cell Research and Therapy, 6, 234.
Shim, G., Lee, S., Han, J., Kim, G., Jin, H., Miao, W., Yi, T. G., Cho, Y. K., Song, S. U., & Oh, Y. K. (2015). Pharmacokinetics and in vivo fate of intra-articularly transplanted human bone marrow-derived clonal mesenchymal stem cells. Stem Cells and Development, 24, 1124–1132.
Herrera, M. B., Bussolati, B., Bruno, S., Morando, L., Mauriello-Romanazzi, G., Sanavio, F., Stamenkovic, I., Biancone, L., & Camussi, G. (2007). Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney International, 72, 430–441.
Wagner, W., Ho, A. D., & Zenke, M. (2010). Different facets of aging in human mesenchymal stem cells. Tissue Engineering Part B Reviews, 16, 445–453.
Rombouts, W. J., & Ploemacher, R. E. (2003). Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia, 17, 160–170.
Liu, X. B., Chen, H., Chen, H. Q., Zhu, M. F., Hu, X. Y., Wang, Y. P., Jiang, Z., Xu, Y. C., Xiang, M. X., & Wang, J. A. (2012). Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantation. Journal of Zhejiang University - Science B, 13, 616–623.
Rook, J. M., Hasan, W., & McCarson, K. E. (2009). Morphine-induced early delays in wound closure: involvement of sensory neuropeptides and modification of neurokinin receptor expression. Biochemical Pharmacology, 77, 1747–1755.
Chrastil, J., Sampson, C., Jones, K. B., & Higgins, T. F. (2013). Postoperative opioid administration inhibits bone healing in an animal model. Clinical Orthopaedics and Related Research, 471, 4076–4081.
This work was supported by the project No. LTAUSA18110 – Inter-Excellence from the Ministry of Education, Youth and Sports of the Czech Republic, grant No. 19-02290S from the Grant Agency of the Czech Republic, project RVO:6798523 from the Institute of Physiology and by the Charles University programs SVV 260435 and 20604315 PROGRES Q43.
Human and Animal Rights
This study did not involve human participants. The experiments with animals were approved by the local Animal Ethics Committee of the Institute of Experimental Medicine of the Czech Academy of Sciences, Prague.
Conflict of Interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Holan, V., Echalar, B., Palacka, K. et al. The Altered Migration and Distribution of Systemically Administered Mesenchymal Stem Cells in Morphine-Treated Recipients. Stem Cell Rev and Rep (2021). https://doi.org/10.1007/s12015-021-10126-w
- Mesenchymal stem cells
- Acute and chronic morphine treatment
- Adhesive molecules
- Cell migration
- Skin graft model